This document discusses models of drug development and how placing development tasks in parallel to minimize time to market can actually increase costs, late-stage attrition, and expected time to market. It presents the "development speed paradox" where serial development processes have a shorter expected time to market despite having a longer cycle time. The document advocates getting the science right early and building opportunities to eliminate molecules earlier in development to improve productivity.
1 of 15
Download to read offline
More Related Content
Pharmaceutical R&D: Looking for a Needle in a Haystack? Torch the Haystack.
2. Torching the Haystack
Business Process Reengineering prompted a
reinvention of pharmaceutical development processes.
Minimizing time to market identified as the key to
improving R&D productivity.
By placing development tasks in parallel, wherever
possible, we minimize time to market for successful
molecules.
3. Torching the Haystack
Before Development Speed Initiative
6321 4 5
3
2
1 64
5
After Development Speed Initiative
Time to Market
6. Torching the Haystack
We optimized the R&D process around an event which
happens less than 10% of the time.
7. Torching the Haystack
By placing tasks in parallel to reduce cycle time we
inadvertently:
Increased R&D costs
Increased late-stage attrition rates, and
Increased expected time to market
Lendrem DW, Lendrem BC Torching the Haystack: Modelling fast-fail strategies in drug
development. Drug Discov Today. 2013 Apr;18(7-8):331-6.
http://dx.doi.org/10.1016/j.drudis.2012.11.011
p
1 - p
硫
1
1-硫1
1-留1
留
1
硫
2
1-硫2
C 2
C 2
C 2
C 2
C 0
C 1
C 1
C 0
C 1
C 1
1-留i
留
i C i
C i
C i
C i
硫
i
1-硫i
1-留2
留
2
Stage i=0 Stage i=1 Stage i=2.... ...Stage i=m
.......
.......
a
b
c
d
8. Example
Torching the Haystack
Time
New 2 2 2 + 2 = 4
Old 1 5 1 + 5 = 6
Lendrem DW More haste, less development speed.
Scrip Magazine. Dec 1995, 22-23.
9. Example
If p=0.10 then the average number of drugs
tested before the first success = 1/p = 10
So the average time to launch the first drug:
= (10 x 1) + 5 = 15 years
= (10 x 2) + 2 = 22 years
Torching the Haystack
New
Old
New 2 2 2 + 2 = 4
Old 1 5 1 + 5 = 6
Lendrem DW More haste, less development speed.
Scrip Magazine. Dec 1995, 22-23.
10. Torching the Haystack
Conclusion?
For high risk projects, the expected time to market is
actually SHORTER for the serial process EVEN
THOUGH THE CYCLE TIME is LONGER.
This is the Development Speed Paradox
Lendrem DW, Lendrem BC The Development Speed Paradox: Can increasing development speed
reduce R&D productivity? Drug Discov Today. 2014 http://dx.doi.org/10.1016/j.drudis.2013.09.002
The faster you go the longer it takes.
12. Torching the Haystack
By placing tasks in parallel to reduce cycle time we
inadvertently:
Increased R&D costs
Increased late-stage attrition rates
Increased expected time to market
As a result, the industry became really slick at delivering
late-stage failures to the market place, precipitating the
current R&D productivity crisis.
Lendrem DW, Lendrem BC Torching the Haystack: Modelling fast-fail strategies in drug
development. Drug Discov Today. 2013 Apr;18(7-8):331-6.
http://dx.doi.org/10.1016/j.drudis.2012.11.011
13. Torching the Haystack
The M25 Effect
Reducing Development Speed may actually increase
R&D throughput.
After Londons major orbital motorway where speed
limits were first reduced in the UK in order to
increase traffic throughput.
Lendrem DW, Lendrem BC The Development Speed Paradox: Can increasing development speed
reduce R&D productivity? Drug Discov Today. 2014 http://dx.doi.org/10.1016/j.drudis.2013.09.002
14. Torching the Haystack
Looking for a needle in a haystack?
Get the science right. Build opportunities to kill
molecules earlier in the development cycle.
Assays that prevent molecules from entering the
development process.
Assays that allow elimination of molecules early in
the development process.
15. Torching the Haystack
Thanks
Richard Peck (Lilly)
Fred Snikeris (Quintiles)
Stephen Senn (CRP-Sante)
Clare Lendrem (NCL)
Frank Bonner (NCL)
Wan-Fai Ng (NCL)
John Isaacs (NCL)
MRG